{"id":"https://openalex.org/W2229660774","doi":"https://doi.org/10.1200/jco.2014.32.26_suppl.163","title":"A phase 1 study of dinaciclib (SCH 727965) in combination with epirubicinin patients with metastatic triple-negative breast cancer.","display_name":"A phase 1 study of dinaciclib (SCH 727965) in combination with epirubicinin patients with metastatic triple-negative breast cancer.","publication_year":2014,"publication_date":"2014-09-10","ids":{"openalex":"https://openalex.org/W2229660774","doi":"https://doi.org/10.1200/jco.2014.32.26_suppl.163","mag":"2229660774"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.26_suppl.163","doi":"https://doi.org/10.1200/jco.2014.32.26_suppl.163","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.26_suppl.163","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070623583","display_name":"Zahi Ibrahim Mitri","orcid":"https://orcid.org/0000-0001-8765-7723","observed_orcids":["https://orcid.org/0000-0001-8765-7723"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zahi Mitri","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houtston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houtston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007764207","display_name":"Kansu Karakas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kansu Karakas","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077026571","display_name":"Nuhad K. Ibrahim","orcid":"https://orcid.org/0000-0001-8660-243X","observed_orcids":["https://orcid.org/0000-0001-8660-243X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nuhad K. Ibrahim","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103723583","display_name":"Ricardo H. \u00c1lvarez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo H. Alvarez","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024613613","display_name":"James L. Murray","orcid":"https://orcid.org/0000-0002-9585-4951","observed_orcids":["https://orcid.org/0000-0002-9585-4951"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L. Murray","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050957502","display_name":"Brian Briones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Briones","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024100813","display_name":"Holly Simmons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Simmons","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102972148","display_name":"Stacy Moulder","orcid":"https://orcid.org/0000-0001-8890-7077","observed_orcids":["https://orcid.org/0000-0001-8890-7077"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacy L. Moulder","raw_affiliation_strings":["Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"26_suppl","first_page":"163","last_page":"163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8389000296592712,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.8389000296592712,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.15160000324249268,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dinaciclib","display_name":"dinaciclib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.6200000047683716},{"id":"https://openalex.org/keywords/cdk2-inhibition","display_name":"CDK2 inhibition","score":0.8410000205039978},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9279999732971191},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.984000027179718},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8873071670532227},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.7981138229370117},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.678508996963501},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6203858256340027},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5817502737045288},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5782665610313416},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5707442164421082},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.523887574672699},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5058824419975281},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.504289984703064},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4802556335926056},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42206746339797974},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40298163890838623},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33319103717803955}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.26_suppl.163","doi":"https://doi.org/10.1200/jco.2014.32.26_suppl.163","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.26_suppl.163","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W345803373","https://openalex.org/W2947240645","https://openalex.org/W3029048558","https://openalex.org/W2034158675","https://openalex.org/W2307174499","https://openalex.org/W2077037832","https://openalex.org/W2984263211","https://openalex.org/W2919093067","https://openalex.org/W2341202074","https://openalex.org/W2018668203"],"abstract_inverted_index":{"163":[0],"Background:":[1],"Low":[2],"molecular":[3],"weight":[4],"cyclin":[5],"E":[6],"(LMW-E)":[7],"isoforms":[8,21],"are":[9,186],"overexpressed":[10],"in":[11,25,51,77,81,188],"a":[12,23,64,119],"majority":[13],"(~70%)":[14],"of":[15,33,37,54,75,88,98,110,118,251,292],"triple-negative":[16],"breast":[17],"cancers":[18],"(TNBC).":[19],"LMW-E":[20],"have":[22],"role":[24],"tumorigenesis,":[26],"likely":[27],"mediated":[28],"through":[29],"binding":[30],"and":[31,171,177,214,257,272,294,307],"activation":[32],"CDK2.":[34],"The":[35,152,290],"combination":[36,78,291],"CDK1/CDK2":[38],"inhibitors,":[39],"such":[40],"as":[41],"dinaciclib,":[42],"with":[43,79,83,95,286,310],"an":[44,301],"anthracycline":[45],"was":[46,135,166,193,238,253,262,274],"found":[47,239],"to":[48,69,159,161,201,229,240,260,276,299],"be":[49,241,300],"synergistic":[50],"decreasing":[52],"viability":[53],"TNBC":[55],"cell":[56],"lines.":[57],"Based":[58],"on":[59,103,115],"this":[60],"data,":[61],"we":[62],"conducted":[63],"phase":[65],"1":[66,105,146,198,254,263],"study":[67],"aimed":[68],"determine":[70],"the":[71,162,189,225,234],"maximum":[72],"tolerated":[73],"dose":[74,109,133,155,236,283],"dinaciclib":[76,99,293],"epirubicin":[80,111,295],"patients":[82,92,124,174,245],"metastatic":[84],"TNBC.":[85],"Methods:":[86],"Cohorts":[87],"at":[89,179],"least":[90],"2":[91,117],"were":[93,175,270],"treated":[94,178],"escalating":[96],"doses":[97],"(20-50":[100],"mg/m2)":[101,113],"given":[102,114],"day":[104,116,121],"followed":[106],"by":[107],"standard":[108],"(75":[112],"21":[120],"cycle.":[122],"All":[123],"received":[125],"pegfilagrastim":[126],"24-48":[127],"hours":[128],"after":[129,197],"chemotherapy.":[130],"No":[131,267],"intra-patient":[132],"escalation":[134,220],"allowed.":[136],"An":[137],"adaptive":[138],"accrual":[139,278],"design":[140],"based":[141],"upon":[142],"toxicity":[143,157],"during":[144],"cycle":[145,199],"determined":[147],"entry":[148],"into":[149],"therapy":[150],"cohorts.":[151],"target":[153],"acceptable":[154],"limiting":[156],"(DLT)":[158],"advance":[160],"next":[163],"treatment":[164,196,268,303],"level":[165,237],"30%.":[167],"Results:":[168],"Between":[169],"9/18/2012":[170],"7/18/2013,":[172],"9":[173],"enrolled":[176],"MD":[180],"Anderson":[181],"Cancer":[182],"Center.":[183],"Patient":[184],"characteristics":[185],"included":[187,204],"Table.":[190],"One":[191],"patient":[192],"taken":[194],"off":[195],"due":[200,228],"toxicity.":[202,230],"DLTs":[203],"febrile":[205],"neutropenia":[206],"(grade":[207,211,216],"3,":[208,212,217],"n=2),":[209],"syncope":[210],"n=2)":[213],"vomiting":[215],"n=1).":[218],"Dose":[219],"did":[221],"not":[222,297],"proceed":[223],"past":[224],"second":[226],"cohort":[227],"After":[231],"further":[232],"accrual,":[233],"first":[235],"too":[242],"toxic.":[243],"Eight":[244],"had":[246],"disease":[247],"progression,":[248],"median":[249,258],"number":[250],"cycles":[252],"(range":[255,265],"1-4),":[256],"time":[259],"progression":[261],"month":[264],"1-3).":[266],"responses":[269],"noted":[271],"it":[273],"decided":[275],"stop":[277],"rather":[279],"than":[280],"explore":[281],"lower":[282],"levels.":[284],"Associated":[285],"significant":[287,311],"toxicities.":[288,312],"Conclusions:":[289],"does":[296],"appear":[298],"effective":[302],"option":[304],"for":[305],"TNBC,":[306],"is":[308],"associated":[309],"Clinical":[313],"trial":[314],"information:":[315],"NCT01624441.":[316],"[Table:":[317],"see":[318],"text]":[319]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}